C
AMLX icon

Covestor’s Amylyx Pharmaceuticals AMLX Stock Holding History

Covestor’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
33
+24
+267% +$371 ﹤0.01% 2029
2026
Q1 		$0 Buy
+9
New +$127 ﹤0.01% 2217
2024
Q3 		– Sell
-43
Closed – – 2166
2024
Q2 		$0 Sell
43
-31
-42% -$60 ﹤0.01% 2200
2024
Q1 		$0 Sell
74
-3,652
-98% -$47.8K ﹤0.01% 2196
2023
Q4 		$55K Buy
3,726
+3,722
+93,050% +$57K 0.04% 804
2023
Q3 		$0 Hold
4
– – ﹤0.01% 2069
2023
Q2 		$0 Hold
4
– – ﹤0.01% 2089
2023
Q1 		$0 Hold
4
– – ﹤0.01% 1969
2022
Q4 		$0 Sell
4
-1
-20% -$35 ﹤0.01% 2015
2022
Q3 		$0 Buy
+5
New +$125 ﹤0.01% 1933

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Covestor's AMLX Position: Q2 2026 in Review

Covestor increased its Amylyx Pharmaceuticals (AMLX) stake by 267% in Q2 2026, buying an estimated $371 and bringing the position to 33 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2029.

Covestor first reported a position in AMLX in Q3 2022 and has held it in 10 quarters since. The position peaked at $55K in Q4 2023. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Covestor held 33 shares of Amylyx Pharmaceuticals worth $1K as of Q2 2026.
  • Covestor bought 24 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $371.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2029 holding.
  • Covestor first reported a position in Amylyx Pharmaceuticals in Q3 2022 and has held it in 10 quarters since.
  • Covestor's Amylyx Pharmaceuticals position peaked at $55K in Q4 2023.
  • 206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.